- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00079573
Comparison of Popular Weight Loss Diets
Benefits & Risks of Popular Weight Loss Diets
Study Overview
Status
Conditions
Detailed Description
Obesity is the single most significant, nutrition-related health issue of the new millennium. Several "medical experts" have designed and promoted weight loss diets that dramatically differ from one another and from the USDA Dietary Guidelines. These diets have gained surprisingly widespread and persistent popularity among Americans despite the lack of evidence supporting their claims. This clinical trial will provide preliminary feasibility data for a full-scale study that will examine health outcomes (e.g., benefits, risks, success) of three popular weight loss diets. The study will investigate behavioral and physiological factors that influence adherence and retention to these diet plans.
Overweight women will be randomly assigned to one of four diets for 1 year: Atkins (extremely low carbohydrate), Zone (low carbohydrate, high protein), Ornish (very low fat), or USDA/Food Pyramid (high carbohydrate/moderate-low fat). Behavioral and physiological data will be collected. Participants attend study visits at baseline, 8 weeks, 6 months, and 1 year. At these visits, measurements will include that will include weight and blood pressure measurements and blood tests. Participants will be asked to complete ten questionnaires over the course of the study to assess behavior and appetite. Participants will also undergo a DEXA scan to assess body composition.
Study Type
Enrollment
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Prevention Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Body mass index (BMI) between 27 and 40 kg/m2
- Weight stable for last 2 months
- Not actively on a weight loss plan
- No plans to move from the area over the next 2 years
- Willing to accept random assignment
Exclusion Criteria
- Pregnant or breastfeeding
- Within 6 months of giving birth or planning to become pregnant in the next 2 years
- Diabetes (type 1 or 2) or history of gestational diabetes
- Renal or liver disease, active neoplasms, or recent myocardial infarction
- Hyper- or hypothyroidism
- Lipid lowering medications or medications known to affect weight/energy expenditure
- Excessive alcohol intake (self-reported, > 3 drinks/day)
- Postmenopausal, including surgical menopause
- Currently under psychiatric care or severely clinically depressed (> 17 on Beck Inventory)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Weight; measured at each study visit
|
|
Percent body fat; measured at each study visit
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Blood lipids (cholesterol, triglycerides); measured at each study visit
|
|
Fasting insulin and glucose; measured at each study visit
|
|
Behavioral variables; measured at each study visit
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Christopher D. Gardner, PhD, Stanford University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21AT001098-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.